Michael Severino

Shares of AbbVie Inc (NYSE: ABBV) were trading higher by nearly 2 percent early Tuesday morning after the company announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Venclexta. Venclexta, a table taken orally, is used for the treatment of patients diagnosed...